Short Interest in Revolution Medicines, Inc. (NASDAQ:RVMDW) Rises By 25.0%

Revolution Medicines, Inc. (NASDAQ:RVMDW) saw a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 500 shares, a growth of 25.0% from the November 15th total of 400 shares. Based on an average daily volume of 36,800 shares, the short-interest ratio is currently 0.0 days.

Revolution Medicines Stock Down 2.2 %

Shares of RVMDW stock traded down $0.01 during mid-day trading on Friday, reaching $0.31. 598 shares of the company were exchanged, compared to its average volume of 18,021. Revolution Medicines has a fifty-two week low of $0.05 and a fifty-two week high of $0.80. The business’s 50 day simple moving average is $0.32 and its 200 day simple moving average is $0.20.

About Revolution Medicines

Revolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies.